Global News
-
Longer interval between first and second Pfizer vaccine boosts antibody levels: Study
T cell levels are well-maintained and antibody levels are higher following a longer interval Universities of Sheffield, Oxford, Liverpool, Newcastle,…
Read More » -
Intas in exclusive licensing agreement with Meiji and Dong-A ST
Intas has been granted exclusive license rights to commercialise DMB-3115 worldwide, excluding Japan, Korea and certain countries in Asia Intas…
Read More » -
Experts call for urgent action to improve physical activity worldwide: The Lancet
Physical inactivity is linked to an increased risk of non-communicable diseases (NCDs) such as heart disease, diabetes and some cancers…
Read More » -
Infor advances in health innovation, transformation with AWS
The initiative is designed to make it easier for health customers to select the right tools and partners for their…
Read More » -
Hologic obtains CE Mark for use of saliva samples with COVID-19 test
The Aptima SARS-CoV-2 test is a molecular diagnostic assay that detects the genetic material of the pathogen Hologic has obtained…
Read More » -
iSTAR Medical to start trial for MINIject in glaucoma patients
Bags US FDA approval iSTAR Medical, a med-tech company developing minimally-invasive implants for glaucoma surgery (MIGS), announced that the US…
Read More » -
The Untold Story releases Zhang Boli’s short documentary on battle against pandemic
Under the promotion of Boli, traditional Chinese medicine intervened in the treatment of COVID-19 patients in the whole process Zhang…
Read More » -
Vessi Medical conducts procedure for bladder cancer using cryotherapy system
The procedure was performed at Rambam Healthcare Campus in Haifa, Israel Vessi Medical has completed the first-in-human case with its…
Read More » -
India Exim Bank study suggests $100 M fund to upgrade health infra across Africa
The fund can be used to construct five 100-bed capacity hospitals across Africa India Exim Bank’s study titled ‘India-Africa Healthcare:…
Read More » -
Lupin launches onychomycosis topical solution in US market
The product will be manufactured at Lupin’s facility in Pithampur Lupin announced the US launch of Tavaborole Topical Solution, 5…
Read More »
